SC 13G/A: Annexon, Inc.
Ticker: ANNX · Form: SC 13G/A · Filed: Feb 13, 2024 · CIK: 1528115
Sentiment: neutral
Topics: sc-13g-a
AI Summary
SC 13G/A filing by Annexon, Inc..
Risk Assessment
Risk Level: low
Filing Stats: 2,339 words · 9 min read · ~8 pages · Grade level 11.5 · Accepted 2024-02-13 18:57:28
Key Financial Figures
- $0.001 — INC. (Name of Issuer) Common Stock, $0.001 par value per share (Title of Class o
Filing Documents
- d753375dsc13ga.htm (SC 13G/A) — 83KB
- d753375dex99a.htm (EX-99.A) — 12KB
- 0001193125-24-034110.txt ( ) — 96KB
SIGNATURES
SIGNATURES After reasonable inquiry and to the best of its knowledge and belief, the undersigned certifies that the information in this statement is true, complete and correct. Dated: February 13,2024 Bain Capital Life Sciences Fund, L.P. By: Bain Capital Life Sciences Partners, LP its general partner By: Bain Capital Life Sciences Investors, LLC its general partner By: /s/ Ricky Sun Name: Ricky Sun Title: Partner BCIP Life Sciences Associates, LP By: Boylston Coinvestors, LLC its general partner By: /s/ Ricky Sun Name: Ricky Sun Title: Authorized Signatory BCLS I Investco, LP By: BCLS I Investco GP, LLC, its general partner By: Bain Capital Life Sciences Fund, L.P., its manager By: Bain Capital Life Sciences Partners, LP, its general partner By: Bain Capital Life Sciences Investors, LLC, its general partner By: /s/ Ricky Sun Name: Ricky Sun Title: Partner